0001179110-16-020662.txt : 20160302 0001179110-16-020662.hdr.sgml : 20160302 20160302170403 ACCESSION NUMBER: 0001179110-16-020662 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160229 FILED AS OF DATE: 20160302 DATE AS OF CHANGE: 20160302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOANALYTICAL SYSTEMS INC CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETT STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lemke Jacqueline M CENTRAL INDEX KEY: 0001546217 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23357 FILM NUMBER: 161477939 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 4 1 edgar.xml FORM 4 - X0306 4 2016-02-29 0 0000720154 BIOANALYTICAL SYSTEMS INC BASI 0001546217 Lemke Jacqueline M 2701 KENT AVENUE WEST LAFAYETTE IN 47906 1 1 0 0 President and CEO Common Shares 2016-02-29 4 P 0 4000 1.1854 A 60685 D Common Shares 2016-02-29 4 P 0 6000 1.17 A 9000 I See Footnote The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.20, inclusive. The reporting person undertakes to provide Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reporting person acts as custodian for accounts which hold these shares for the benefit of the reporting person's minor children. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. /s/ Jill Blumhoff, attorney-in-fact for Jacqueline M. Lemke 2016-03-02